Dr. Barbara Gitlitz, M.D

NPI: 1467488015
Total Payments
$68,433
2024 Payments
$159.31
Companies
7
Transactions
44

Payment Breakdown by Category

Other$52,140 (76.2%)
Consulting$7,978 (11.7%)
Travel$6,951 (10.2%)
Food & Beverage$1,364 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $52,140 11 76.2%
Consulting Fee $7,978 3 11.7%
Travel and Lodging $6,951 13 10.2%
Food and Beverage $1,364 17 2.0%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $64,924 34 $0 (2017)
ARIAD Pharmaceuticals, Inc. $2,813 1 $0 (2017)
Lilly USA, LLC $467.51 4 $0 (2017)
Coherus Biosciences Inc. $159.31 2 $0 (2024)
Celgene Corporation $42.55 1 $0 (2017)
AstraZeneca Pharmaceuticals LP $16.24 1 $0 (2017)
PFIZER INC. $11.30 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $159.31 2 Coherus Biosciences Inc. ($159.31)
2017 $68,274 42 Genentech USA, Inc. ($64,924)

All Payment Transactions

44 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/22/2024 Coherus Biosciences Inc. Udenyca (Biological) Food and Beverage In-kind items and services $65.22 General
Category: Granulocyte colony stimulating factor
01/29/2024 Coherus Biosciences Inc. Udenyca (Biological) Food and Beverage In-kind items and services $94.09 General
Category: Granulocyte colony stimulating factor
05/30/2017 Genentech USA, Inc. Avastin (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,280.00 General
Category: BioOncology
05/30/2017 Genentech USA, Inc. Avastin (Biological) Travel and Lodging Cash or cash equivalent $828.32 General
Category: BioOncology
05/30/2017 Genentech USA, Inc. Avastin (Biological) Food and Beverage In-kind items and services $125.00 General
Category: BioOncology
05/17/2017 Genentech USA, Inc. Avastin (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,280.00 General
Category: BioOncology
05/17/2017 Genentech USA, Inc. Avastin (Biological) Travel and Lodging Cash or cash equivalent $742.69 General
Category: BioOncology
05/17/2017 Genentech USA, Inc. Avastin (Biological) Food and Beverage In-kind items and services $89.00 General
Category: BioOncology
05/16/2017 Genentech USA, Inc. TECENTRIQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,280.00 General
Category: BioOncology
05/16/2017 Genentech USA, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $100.00 General
Category: BioOncology
05/12/2017 Genentech USA, Inc. TECENTRIQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,300.00 General
Category: BioOncology
04/27/2017 Genentech USA, Inc. Avastin (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,280.00 General
Category: BioOncology
04/27/2017 Genentech USA, Inc. Avastin (Biological) Travel and Lodging Cash or cash equivalent $738.88 General
Category: BioOncology
04/27/2017 Genentech USA, Inc. Avastin (Biological) Travel and Lodging Cash or cash equivalent $180.17 General
Category: BioOncology
04/27/2017 Genentech USA, Inc. Avastin (Biological) Food and Beverage In-kind items and services $73.26 General
Category: BioOncology
04/06/2017 Genentech USA, Inc. TECENTRIQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,280.00 General
Category: BioOncology
04/06/2017 Genentech USA, Inc. TECENTRIQ (Biological) Travel and Lodging Cash or cash equivalent $860.10 General
Category: BioOncology
04/06/2017 Genentech USA, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $108.34 General
Category: BioOncology
03/18/2017 Genentech USA, Inc. Avastin (Biological), Tarceva, Alecensa Consulting Fee Cash or cash equivalent $3,500.00 General
Category: BioOncology
03/18/2017 Genentech USA, Inc. Avastin (Biological), Tarceva, Alecensa Travel and Lodging In-kind items and services $387.88 General
Category: BioOncology
03/18/2017 Genentech USA, Inc. Avastin (Biological), Tarceva, Alecensa Food and Beverage In-kind items and services $135.89 General
Category: BioOncology
03/15/2017 Genentech USA, Inc. TECENTRIQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,300.00 General
Category: BioOncology
03/15/2017 Genentech USA, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $120.67 General
Category: BioOncology
03/10/2017 Lilly USA, LLC ERBITUX (Drug), CYRAMZA Food and Beverage In-kind items and services $19.24 General
Category: Oncology
03/09/2017 Lilly USA, LLC CYRAMZA (Drug) Food and Beverage In-kind items and services $20.91 General
Category: Oncology

About Dr. Barbara Gitlitz, M.D

Dr. Barbara Gitlitz, M.D is a Medical Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467488015.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Gitlitz, M.D has received a total of $68,433 in payments from pharmaceutical and medical device companies, with $159.31 received in 2024. These payments were reported across 44 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($52,140).

Practice Information

  • Specialty Medical Oncology
  • Location Los Angeles, CA
  • Active Since 06/24/2006
  • Last Updated 04/02/2014
  • Taxonomy Code 207RX0202X
  • Entity Type Individual
  • NPI Number 1467488015

Products in Payments

  • Avastin (Biological) $35,675
  • TECENTRIQ (Biological) $24,785
  • Tarceva (Drug) $4,464
  • brigatinib (Drug) $2,813
  • ALIMTA (Drug) $427.36
  • Udenyca (Biological) $159.31
  • Abraxane (Drug) $42.55
  • CYRAMZA (Drug) $20.91
  • ERBITUX (Drug) $19.24
  • TAGRISSO (Drug) $16.24
  • XALKORI (Drug) $11.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Oncology Doctors in Los Angeles